Charles Schoch - Jun 25, 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Financial Officer
Signature
/s/ Charles Schoch
Stock symbol
CADL
Transactions as of
Jun 25, 2025
Transactions value $
$24,999
Form type
4
Date filed
6/26/2025, 08:30 AM
Previous filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schoch Charles Chief Financial Officer C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch 2025-06-26 0002007349

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $25K +5.35K +14.07% $4.67 43.4K Jun 25, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.